New heart scan agent aims to spot dangerous blockages more accurately

NCT ID NCT07439133

Recruiting now Diagnosis Sponsor: Sinotau Pharmaceutical Group Source: ClinicalTrials.gov ↗

First seen Mar 04, 2026 · Last updated May 15, 2026 · Updated 14 times

Summary

This study tests whether a new injection called XTR004, used during a PET heart scan, can better identify significant blockages in the heart's arteries compared to standard scans. About 395 adults with known or suspected stable coronary artery disease will receive the injection and undergo imaging. The goal is to see if this method improves detection of blood-flow-limiting stenosis, which could help guide treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Beijing Anzhen Hospital, Capital Medical University
RECRUITING

Beijing, China
Beijing Tongren Hospital
RECRUITING

Beijing, China
Peking Union Medical College Hospital
RECRUITING

Beijing, China
TEDA International Cardiovascular Hospital
RECRUITING

Tianjin, China
The First People's Hospital of Foshan
RECRUITING

Foshan, China

Conditions

Explore the condition pages connected to this study.

CORONARY ARTERY DISEASE (CAD)